These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7413014)

  • 1. Immunogenetic studies of multiple sclerosis patients in Caithness County, Scotland.
    Robertson P; Ward P; Brostoff J; Pack S; Festenstein H; Sacks J; Rosenberg RA; Peters E; Stenning P; Zabriskie JB
    Neuropathol Appl Neurobiol; 1980; 6(4):299-305. PubMed ID: 7413014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measles antibodies and histocompatibility types in multiple sclerosis.
    Fewster ME; Ames FR; Botha MC
    J Neurol Sci; 1979 Sep; 43(1):19-26. PubMed ID: 521827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measles antibody titers in multiple sclerosis patients and HLA-matched and unmatched siblings.
    Visscher BR; Sullivan CB; Detels R; Madden DL; Sever JL; Terasaki PI; Park MS; Dudley JP
    Neurology; 1981 Sep; 31(9):1142-5. PubMed ID: 6267516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple sclerosis in the Orkney and Shetland Islands. V: The effect on viral titres of histocompatibility determinants.
    Poskanzer DC; Sever JL; Terasaki PI; Prenney LB; Sheridan JL; Park MS
    J Epidemiol Community Health; 1980 Dec; 34(4):265-70. PubMed ID: 7241025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA antigens and antibody responses to measles and rubella viruses in multiple sclerosis.
    Ilonen J; Herva E; Reunanen M; Panelius M; Meurman O; Arstila P; Tiilikainen A
    Acta Neurol Scand; 1977 Apr; 55(4):299-309. PubMed ID: 855642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA types and immunity in multiple sclerosis.
    Visscher BR; Myers LW; Ellison GW; Malmgren RM; Detels R; Lucia MV; Madden DL; Sever JL; Park MS; Coulson AH
    Neurology; 1979 Dec; 29(12):1561-5. PubMed ID: 574218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measles antibodies as related to HL-A types in multiple sclerosis.
    Paty DW; Furesz J; Boucher DW; Rand CG; Stiller CR
    Neurology; 1976 Jul; 26(7):651-5. PubMed ID: 945513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA and the immune response to measles in multiple sclerosis.
    Myers LW; Ellison GW; Fewster ME; Terasaki P; Opelz G
    Neurology; 1976 Jun; 26(6 PT 2):54-5. PubMed ID: 944896
    [No Abstract]   [Full Text] [Related]  

  • 9. Histocompatibility types and measles antibodies in multiple sclerosis.
    Fewster ME; Myers LW; Ellison GW; Walford RL
    J Neurol Sci; 1977 Nov; 34(2):287-96. PubMed ID: 925715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA in multiple sclerosis. Relationship to measles antibody, mitogen responsiveness and clinical course.
    Paty DW; Dossetor JB; Stiller CR; Cousin HK; Marchuk L; Furesz J; Boucher DW
    J Neurol Sci; 1977 Jul; 32(3):371-9. PubMed ID: 886362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic basis of multiple sclerosis: HLA antigens, disease progression, and oligoclonal IgG in CSF.
    Stendahl-Brodin L; Link H; Möller E; Norrby E
    Acta Neurol Scand; 1979 Jun; 59(6):297-308. PubMed ID: 90443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial multiple sclerosis: clinical, histocompatibility, and viral serological studies.
    Eldridge R; McFarland H; Sever J; Sadowsky D; Krebs H
    Ann Neurol; 1978 Jan; 3(1):72-80. PubMed ID: 418737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenetic analysis and serum viral antibody titers in multiple sclerosis.
    Whitaker JN; Herrmann KL; Rogentine GN; Stein SF; Kollins LL
    Arch Neurol; 1976 Jun; 33(6):399-403. PubMed ID: 938263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Correlation between progression of multiple sclerosis and immunogenetic as well as immunological factors].
    Cendrowski W
    Neurol Neurochir Pol; 1978; 12(2):157-60. PubMed ID: 79154
    [No Abstract]   [Full Text] [Related]  

  • 15. The prevalence of multiple sclerosis in the Outer Hebrides compared with north-east Scotland and the Orkney and Shetland Islands.
    Dean G; Goodall J; Downie A
    J Epidemiol Community Health; 1981 Jun; 35(2):110-3. PubMed ID: 7299334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple sclerosis immunogenetics: a) associations between HL-A antigens and high measles antibody levels. b) existence of common MLR/immune response determinants in MS patients.
    Cazzullo CL; Smeraldi E
    Boll Ist Sieroter Milan; 1974; 53(5):615-24. PubMed ID: 4282585
    [No Abstract]   [Full Text] [Related]  

  • 17. Multiple sclerosis in the Orkney and Shetland Islands. III: Histocompatibility determinants.
    Poskanzer DC; Terasaki PI; Prenney LB; Sheridan JL; Park MS
    J Epidemiol Community Health; 1980 Dec; 34(4):253-7. PubMed ID: 6972433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-DW2, viral immunity and family studies in multiple sclerosis.
    Stewart GJ; Basten A; Guinan J; Bashir HV; Cameron J; McLeod JG
    J Neurol Sci; 1977 Jun; 32(2):153-67. PubMed ID: 874517
    [No Abstract]   [Full Text] [Related]  

  • 19. Hypocomplementaemic and normocomplementaemic multiple sclerosis. Genetic determinism and association with specific HLA determinants (B18 and B7).
    Trouillas P; Betuel H
    J Neurol Sci; 1977 Jul; 32(3):425-35. PubMed ID: 886365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of immunologic and immunogenetic evaluation in multiple sclerosis.
    Jozefczyk PB; Kelly RH; Rabin BS
    Immunol Commun; 1984; 13(4):371-9. PubMed ID: 6434406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.